LOVENOX PI PDF
LOVENOX® is indicated to help reduce the risk of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE). Read full important safety. /83/EC for Lovenox and associated names, in order to resolve divergences The PI was split as follows according to the indications the. Save money on your Lovenox® Injection prescription by switching to Teva’s FDA- approved generic version, Enoxaparin Sodium Injection, USP.
|Published (Last):||28 November 2006|
|PDF File Size:||19.51 Mb|
|ePub File Size:||3.39 Mb|
|Price:||Free* [*Free Regsitration Required]|
Learn how to get this Teva generic Teva’s generic medications are available in most pharmacies across the United States, though not all pharmacies carry the same Teva medications. A linear relationship between anti-Factor Xa plasma clearance and creatinine clearance at steady state has been observed, which indicates decreased clearance of enoxaparin sodium in patients with reduced renal function.
Lovenox is a sterile aqueous solution containing enoxaparin sodium, a low molecular weight heparin. Remove the needle shield by pulling it straight off the syringe see Figure A. The mean treatment duration for enoxaparin was 6. The use of a tuberculin syringe or equivalent is recommended when using Lovenox multiple-dose vials to assure withdrawal of the appropriate volume of drug. The site of the procedure should be observed for signs of bleeding or hematoma formation [see Dosage and Administration 2.
If neurological compromise is noted, urgent treatment is necessary.
Subcutaneous Injection Technique Patients should be lying down and Lovenox administered by deep subcutaneous injection. Weight After repeated subcutaneous 1.
The usual lovenoz of administration is 6 to 11 days; up to 14 days of Lovenox has been administered in the controlled clinical trial. To avoid the possible mixture of Lovenox with other drugs, the intravenous access chosen should be flushed with a sufficient amount of saline or dextrose solution prior to and following the intravenous bolus administration loveox Lovenox to clear the port of drug.
Do not remove by pulling on the plunger as this may damage the syringe. For intravenous use i. Other loveonx experience including postmarketing surveillance and literature reports has not revealed additional differences in the safety of Lovenox between geriatric and younger patients.
The combined incidence of death or myocardial infarction at all time points was lower for Lovenox compared to standard heparin therapy, but did not achieve statistical significance.
Hip or Knee Replacement Surgery In patients undergoing hip or knee replacement surgery, the recommended dose of Lovenox is 30 mg every 12 hours administered by subcutaneous injection. Patients should be lying down and Lovenox administered by deep subcutaneous injection. The overall treatment effect of enoxaparin as compared to the unfractionated heparin is shown at the bottom of the figure. Pregnancy alone confers an increased risk for thromboembolism that is even higher for women with thromboembolic disease and certain high risk pregnancy conditions.
There is a similar increase in endpoint event rate when enoxaparin was discontinued, suggesting that it too was discontinued too soon in this study. A total of pregnancies resulted in live births. Lovenox may be safely administered with normal saline solution 0.
Enoxaparin Sodium Injection, USP
After hemostasis was established, treatment was initiated 12 to 24 hours after surgery and was continued up to 15 days after surgery. Patients ranged in age from 19 to 96 years mean age Each of these medicines has its own instructions for use.
Lovenox multiple-dose vials are not approved for use in neonates or infants. All pregnancies have a background risk of birth defect, loss, or other adverse outcome regardless of drug exposure.
The 99 patients with total knee replacement ranged in age from 42 to 85 years mean age Likewise, although a specific recommendation for timing of a subsequent Lovenox dose after catheter removal cannot be made, consider delaying this next dose for at least four hours, based on a benefit-risk assessment considering both the risk for thrombosis and the risk for bleeding in the context of the procedure and patient risk factors.
TGA eBS – Product and Consumer Medicine Information
Lovenox 40 mg subcutaneously, administered once a day, beginning 2 hours prior to surgery and continuing for a maximum of 12 days after surgery, was comparable to heparin U every 8 hours subcutaneously in reducing the risk of DVT. In a single study, elimination rate appeared similar but AUC was two-fold higher than control population, after a single 0. Activation of the safety system may cause minimal splatter of fluid. Consider these risks when scheduling patients for spinal procedures.
Keep out of the reach of ip. Lovenox was equivalent to standard heparin therapy in reducing the risk of recurrent venous thromboembolism. The incidence of proximal and total DVT after surgery was significantly lower for Lovenox compared to placebo. Where can I find Teva medications? Lovenox should be administered through an intravenous line.
The risk of these events is higher with the use of postoperative indwelling epidural catheters, with the concomitant use of additional drugs affecting hemostasis such as NSAIDs, with traumatic or repeated epidural or spinal puncture, or in patients with a history of spinal surgery or spinal deformity [see Boxed WarningAdverse Reactions 6.
Prophylaxis of ischemic complications of unstable angina and non—Q-wave myocardial infarction, when concurrently administered with aspirin. Steady-state enoxaparin activity levels are well predicted ;i single-dose pharmacokinetics. Insufficient data, the underlying disease loevnox the possibility of inadequate anticoagulation complicate the evaluation of these cases.
Most of these reports occurred in patients who also had conditions that tend toward the development of hyperkalemia e.
Teva’s generic of Lovenox® Injection: Enoxaparin Sodium Injection, USP
Patients ranged in age from 47 to 87 years mean age The usual duration of administration is 7 to 10 days; up to 14 days administration has been administered in clinical trials. Women with mechanical prosthetic heart valves may be at higher risk for thromboembolism during pregnancy and, when pregnant, have a higher rate of fetal loss from stillbirth, spontaneous abortion, and premature delivery.
In a double-blind study, Lovenox 30 mg every 12 hours subcutaneously was compared to placebo in patients undergoing knee replacement surgery.
Circulating antibodies may persist for several years. All patients were treated with aspirin for a minimum of 30 days. Indication Dose DVT prophylaxis in abdominal surgery.